RecruitingNot ApplicableNCT07008001

Assessment of DOT Spectacles in Chinese Children Extension

Clinical Assessment of DOT Spectacle Lenses in Chinese Children Extension

Sponsor

SightGlass Vision, Inc.

Enrollment

175 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Myopia Juvenile Myopia

Summary

This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

Eligibility

Min Age: 8 YearsMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Novel spectacle lens design for people with juvenile myopia and myopia. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 8 Years to 16 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.